Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.
JCI Insight. 2019 Mar 12;5(8):e125341. doi: 10.1172/jci.insight.125341.
JCI Insight. 2019.
PMID: 30860495
Free PMC article.